Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation

Gastroenterology. 1997 Apr;112(4):1121-8. doi: 10.1016/s0016-5085(97)70122-7.

Abstract

Background & aims: Intestinal transplantation is a feasible therapy for patients with short-bowel syndrome. However, cytomegalovirus (CMV) enteritis can cause complications. The aim of this study was to investigate the value of polymerase chain reaction (PCR)-based detection methods for CMV in the management of patients with small bowel transplants.

Methods: Comparative evaluation of PCR with histopathology, shell-vial assay, and tube culture of intestinal biopsy specimens was used for the diagnosis of CMV enteritis in 21 patients.

Results: Ten patients experienced 21 episodes of CMV enteritis, diagnosed by histopathology, virology, or both. PCR had a sensitivity and specificity of 96% and 69%, respectively, compared with traditional methods, whereas the positive and negative predictive values were 35% and 99%, respectively. Three+ and 4+ signals corresponded to a specificity of 91% and positive predictive value of 59%, respectively. CMV was detected by PCR a median of 11 days (range, 0-32) earlier than other methods and lasted a median of 40 days (range, 21-80) in the 13 episodes, which became PCR-negative and in those patients who developed asymptomatic infection. In 8 episodes, CMV by PCR never became negative and was associated with a relapse of disease confirmed by other methods.

Conclusions: PCR is a sensitive method for the early detection of CMV in intestinal biopsy specimens and can be used for preemptive therapy after intestinal transplantation.

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Blood / virology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / epidemiology
  • DNA / genetics*
  • Digestive System / virology
  • Enteritis / drug therapy
  • Enteritis / epidemiology
  • Enteritis / virology*
  • Ganciclovir / therapeutic use
  • Humans
  • Incidence
  • Intestines / pathology
  • Intestines / transplantation*
  • Polymerase Chain Reaction*
  • Postoperative Complications*

Substances

  • Antiviral Agents
  • DNA
  • Ganciclovir